Categories AlphaGraphs, Earnings, Health Care
AbbVie (ABBV) Q2 2023 Earnings: Key financials and quarterly highlights
AbbVie (NYSE: ABBV) reported second quarter 2023 earnings results today.
Worldwide net revenues were $13.8 billion, down 4.9% on a reported basis, or 4.2% on an operational basis.
Net earnings attributable to AbbVie Inc. were $2 billion, or $1.14 per share, compared to $924 million, or $0.51 per share, last year. Adjusted EPS was $2.91.
AbbVie is raising its full-year 2023 adjusted EPS guidance to $10.90-11.10 from the previous range of $10.57-10.97.
Prior performance
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
